Adobe Inc.Download PDFPatent Trials and Appeals BoardDec 15, 20202020003429 (P.T.A.B. Dec. 15, 2020) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 14/508,141 10/07/2014 Ritwik Sinha AD01.4429US01 8824 111003 7590 12/15/2020 Adobe / Finch & Maloney PLLC 50 Commercial Street Manchester, NH 03101 EXAMINER WALKER III, GEORGE H ART UNIT PAPER NUMBER 3683 NOTIFICATION DATE DELIVERY MODE 12/15/2020 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): docketing@finchmaloney.com nmaloney@finchmaloney.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte RITWIK SINHA, SHIV KUMAR SAINI, and ANANDHAVELU N Appeal 2020-003429 Application 14/508,141 Technology Center 3600 Before CHARLES N. GREENHUT, JEREMY M. PLENZLER, and LEE L. STEPINA, Administrative Patent Judges. PLENZLER, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Pursuant to 35 U.S.C. § 134(a), Appellant1 appeals from the Examiner’s decision to reject claims 1–3, 5, 7, 22–24, 26, 27, and 30–37. We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM. 1 We use the word Appellant to refer to “applicant” as defined in 37 C.F.R. § 1.42(a). Appellant identifies the real party in interest as Adobe Inc. Appeal Br. 3. Appeal 2020-003429 Application 14/508,141 2 CLAIMED SUBJECT MATTER The claims are directed to a method for evaluating a way in which a marketer can interact and/or communicate with a consumer. Claim 1, reproduced below, is illustrative of the claimed subject matter: 1. A method for evaluating the incremental effect of a marketing channel, the method comprising: receiving consumer touch data that characterizes interactions between at least one marketer and a plurality of consumers, wherein each of the interactions is associated with at least one of a plurality of marketing channels, wherein each of the consumers belongs to at least one of a plurality of market segments, and wherein the plurality of market segments are collectively defined by a market segment variable; receiving consumer response data that characterizes an outcome of each of the interactions in terms of a conversion parameter and a revenue value; generating a statistical model that is configured to determine (a) a conversion probability as a conversion function of a vector of a subset of the interactions, and (b) an expected revenue as a revenue function of the vector, wherein the statistical model is based on the consumer touch data and the consumer response data; for a particular one of the plurality of marketing channels, determining an attribution parameter based on a first conversion probability predicated on inclusion of the particular marketing channel in the vector and a second conversion probability predicated on exclusion of the particular marketing channel from the vector, wherein the first and second conversion probabilities are calculated based on the statistical model; for the particular marketing channel, determining a revenue attribution parameter based on a difference between a first expected revenue predicated on inclusion of the particular marketing channel in the vector and a second expected revenue predicated on exclusion of the particular marketing channel from Appeal 2020-003429 Application 14/508,141 3 the vector, wherein the first and second expected revenues are calculated based on the statistical model; determining a collection of attribution parameters for each of the market segments; and determining an Akaike information criterion coefficient that quantifies an extent to which the collection of attribution parameters varies between market segments defined by the market segment variable. REJECTION2 Claims 1–3, 5, 7, 22–24, 26, 27, and 30–37 are rejected under 35 U.S.C. § 101 as being patent-ineligible. OPINION The Examiner determines that the claims are patent-ineligible under 35 U.S.C. § 101. Final Act. 6–8. Appellant’s contentions focus on claim 1. Appeal Br. 6 (“For the purposes of the arguments presented with respect to the rejections under § 101, independent Claim 1 is considered representative of Claims 1–3, 5, 7, 22–24, 26, 27, and 30–37.”). Claims 2, 3, 5, 7, 22–24, 26, 27, and 30–37 stand or fall with claim 1. See 37 C.F.R. § 41.37(c)(1)(iv). Section 101 of the Patent Act provides that “any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof” is patent eligible. 35 U.S.C. § 101. Claim 1 falls within the literal scope of this provision because it recites a process. The Supreme Court, however, has long recognized an implicit exception to this section: “Laws of nature, natural phenomena, and abstract 2 The Examiner’s rejection under 35 U.S.C. § 103 has been withdrawn. See Ans. 3. Appeal 2020-003429 Application 14/508,141 4 ideas are not patentable.” Alice Corp. v. CLS Bank lnt’l, 573 U.S. 208, 216 (2014) (quoting Ass’n for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576, 589 (2013)). To determine whether a claim falls within one of these excluded categories, the Court has set out a two-part framework. The framework requires us first to consider whether the claim is “directed to one of those patent-ineligible concepts.” Alice, 573 U.S. at 217. If so, we then examine “the elements of each claim both individually and ‘as an ordered combination’ to determine whether the additional elements ‘transform the nature of the claim’ into a patent-eligible application.” Alice, 573 U.S. at 217 (quoting Mayo Collaborative Servs. v. Prometheus Labs., Inc., 566 U.S. 66, 78, 79 (2012)). That is, we examine the claims for an “inventive concept,” “an element or combination of elements that is ‘sufficient to ensure that the patent in practice amounts to significantly more than a patent upon the [ineligible concept] itself.’” Alice, 573 U.S. at 217–18 (alteration in original) (quoting Mayo, 566 U.S. at 72–73). Under the 2019 Eligibility Guidance, to decide whether a claim is “directed to” an abstract idea, we evaluate whether the claim (1) recites an abstract idea grouping listed in the guidance and (2) fails to integrate the recited abstract idea into a practical application. See 2019 Revised Patent Subject Matter Eligibility Guidance, 84 Fed. Reg. 50, 51 (Jan. 7, 2019) (“2019 Eligibility Guidance”).3 The groupings of abstract ideas listed in the guidance include, for example: “Certain methods of organizing human activity . . . including . . . advertising, marketing or sales activities or 3 An update to the 2019 Revised Patent Subject Matter Eligibility Guidance issued in October 2019 (“October 2019 Update,” available at https:// www.uspto.gov/sites/default/files/documents/peg_oct_2019_update.pdf). Appeal 2020-003429 Application 14/508,141 5 behaviors.” 2019 Eligibility Guidance, 84 Fed. Reg. at 52. If the claim is “directed to” an abstract idea, as noted above, we then determine whether the claim recites an inventive concept. The guidance explains that, when making this determination, we should consider whether the additional claim elements add “a specific limitation or combination of limitations that are not well-understood, routine, conventional activity in the field” or “simply append[] well-understood, routine, conventional activities previously known to the industry.” 2019 Eligibility Guidance, 84 Fed. Reg. at 56. Step 2(A), Prong 1 The Examiner explains that “[t]he[] steps, as drafted, are processes that, under their broadest reasonable interpretations, evaluate the variability of attribution parameters between marketing channels and market segments, a marketing activity,” which “falls within the ‘Certain Methods of Organizing Human Activity’ grouping of abstract ideas.” Final Act. 7. Appellant responds that “[n]one of the features recited in Claim 1 can be understood as ‘advertising, marketing or sales activities or behaviors’ as that term is used in the Revised Guidance.” Appeal Br. 11. Specifically, Appellant contends that “simply receiving [consumer touch and consumer response] data cannot be characterized as ‘advertising, marketing or sales activities or behaviors.’” Id. Appellant contends that “the Examiner has erred in conflating the concepts of activities or behaviors with simply receiving data that relates to interactions between a marketer and consumers” because “[m]erely receiving data about marketing is not a marketing activity or behavior.” Id. Appellant’s contentions are not persuasive. Appeal 2020-003429 Application 14/508,141 6 Receiving the marketing data as recited in the steps noted above is the initial step in the “advertising, marketing or sales activities.” See Ans. 4 (“[R]eceiving data, in and of itself, is not a marketing activity. However, receiving data is a necessary beginning point for any market research.”). That is, receiving this marketing data is insignificant pre-solution activity. As for “generating a statistical model,” “determining . . . parameter[s] . . . based on the statistical model,” and “determining an Akaike information criterion coefficient,” the Examiner explains that the “generating” and “determining” steps are market research, which is included in the abstract idea. Ans. 4. Appellant again disputes the Examiner’s determination that these steps recite an abstract idea. Appeal Br. 11–12. Appellant contends that “such data processing functionality does not involve marketing goods or services to potential consumers,” and “[t]he fact that the processed data characterizes marketer-consumer interactions does not transform such data processing into an ‘advertising, marketing, or sales’ activity or behavior.” Id. at 12. Appellant contends that its “conclusion is supported by the example advertising, marketing or sales activities or behaviors that are provided in the October 2019 PEG Update” because “[a]ll of these examples describe specific activity or behaviors that are undertaken in the course of advertising, marketing, or selling,” which “include using advertising as an exchange or currency, offer-based price optimization, and structuring of a sales force or marketing company.” Id. citing (October 2019 Update, 6). Again, Appellant’s contentions are not persuasive. As noted above, Appellant acknowledges that the “data processing functionality” is used to characterize marketing activities. The fact that data Appeal 2020-003429 Application 14/508,141 7 processing is employed does not mean that data processing is not also part of the recited abstract idea. That the examples cited in the October 2019 Update do not recite the exact same language as Appellant’s claims does not mean they do not apply to Appellant’s claims. For example, Appellant contends that the “offer-based price optimization” example is not like its recited “generating” and “determining” steps. Appeal Br. 12 (citing (October 2019 Update, 6). The cited portion of the October 2019 Update, as well as the 2019 Eligibility Guidance, cites OIP Techs., Inc. v. Amazon.com, Inc., 788 F.3d 1359, 1362–63 (Fed. Cir. 2015). See, 2019 Eligibility Guidance, 84 Fed. Reg. at 52 n13; October 2019 Update, 6. In OIP, the court characterized the claim at issue as including limitations such as “gathering statistics” and “using that data to estimate outcomes.” OIP, 788 F.3d at 1361. Like Appellant’s claims, the “offer-based price optimization” in OIP is based on data processing. Moreover, we note that the “generating” and “determining” steps could alternatively be characterized as mathematical concepts. See October 2019 Update, 2 (“A claim can recite more than one judicial exception.”). The 2019 Eligibility Guidance characterizes another abstract idea as “Mathematical concepts—mathematical relationships, mathematical formulas or equations, mathematical calculations.” 2019 Eligibility Guidance, 84 Fed. Reg. at 52. As made clear in Appellant’s Specification, “generating a statistical model” and “determining an Akaike information criterion coefficient” are mathematical formulas or equations. See, e.g., Spec. ¶¶ 34, 42. The steps involving “determining . . . parameter[s]” involve mathematical calculations based on the formulas noted above. Appeal 2020-003429 Application 14/508,141 8 Consistent with the Examiner’s determinations, every step in claim 1 recites an abstract idea. Step 2(A), Prong 2 The Examiner determines that “Claim 1 does not recite any additional elements which might integrate the abstract ideas into a practical application.” Final Act. 7. Appellant contends that “determining an Akaike information criterion coefficient” is a practical application. Appeal Br. 13–14. Because, as explained above, we agree with the Examiner that claim 1 recites only abstract ideas, it does not include any practical application. Accordingly, claim 1 is directed to an abstract idea. Step 2(B) Because we agree with the Examiner that claim 1 is directed to an abstract idea, we next determine whether the claim provides an inventive concept. See 2019 Eligibility Guidance, 84 Fed. Reg. at 56. This requires us to evaluate whether the additional claim elements add “a specific limitation or combination of limitations that are not well-understood, routine, conventional activity in the field” or “simply append[] well-understood, routine, conventional activities previously known to the industry, specified at a high level of generality.” Id. The Examiner determines that “[t]he claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception.” Appeal Br. 7. Appellant contends that “[o]ne example of such an ‘additional element’ is ‘generating a statistical model . . . based on the consumer touch data and the consumer response data’” and “[a]nother example of such an ‘additional element’ is ‘determining an Akaike information criterion Appeal 2020-003429 Application 14/508,141 9 coefficient . . . that quantifies an extent to which the collection of attribution parameters varies between market segments defined by the market segment variable.’” Appeal Br. 15. Appellant’s contentions are not persuasive. As noted above, there is nothing in claim 1 other than abstract ideas. The steps Appellant identifies as providing an inventive concept form part of the recited abstract ideas, and the Examiner is not required to show that the abstract ideas are well-understood, routine, and conventional. See, e.g., Bridge & Post, Inc. v. Verizon Commc’ns, Inc., 778 F. App’x 882, 892 (Fed. Cir. 2019) (“At Alice step two we assess ‘whether the claim limitations other than the invention’s use of the ineligible concept to which it was directed were well-understood, routine, and conventional.’” (quoting BSG Tech LLC v. BuySeasons, Inc., 899 F.3d 1281, 1290 (Fed. Cir. 2018))); BSG Tech, 899 F.3d at 1290 (“[T]he relevant inquiry is not whether the claimed invention as a whole is unconventional or non-routine. . . . It has been clear since Alice that a claimed invention’s use of the ineligible concept to which it is directed cannot supply the inventive concept that renders the invention ‘significantly more’ than that ineligible concept.” (first emphasis added)). Accordingly, claim 1 does not add any inventive concept. Conclusion For the reasons set forth above, after applying the 2019 Eligibility Guidance, we sustain the Examiner’s decision to reject claims 1–3, 5, 7, 22– 24, 26, 27, and 30–37 under 35 U.S.C. § 101. CONCLUSION The Examiner’s rejection is affirmed. Appeal 2020-003429 Application 14/508,141 10 DECISION SUMMARY In summary: Claims Rejected 35 U.S.C. § Reference(s)/Basis Affirmed Reversed 1–3, 5, 7, 22–24, 26, 27, 30–37 101 Patent Eligibility 1–3, 5, 7, 22–24, 26, 27, 30–37 TIME PERIOD FOR RESPONSE No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 1.136(a)(1)(iv). AFFIRMED Copy with citationCopy as parenthetical citation